Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 99
- −56 vs. Q1 2022
- Portfolio value
- $241.2M
- −$87.5M (−26.6%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CLDXCelldex Therapeutics, Inc. | COM NEW | 537,958 | $14.5M | 6.0% | 00.0% | Unchanged | History |
| ESPREsperion Therapeutics, Inc. | COM | 2,054,602 | $13.1M | 5.4% | +2,054,602 | New | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 160,116 | $12.8M | 5.3% | +50,000+45.4% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 100,000 | $12.7M | 5.2% | +50,000+100.0% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 1,408,116 | $11.6M | 4.8% | +325,000+30.0% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 40,000 | $11.3M | 4.7% | +15,000+60.0% | Added | History |
| ALTAltimmune, Inc. | COM NEW | 897,359 | $10.5M | 4.4% | +897,359 | New | History |
| UTHRUnited Therapeutics Corp | COM | 40,000 | $9.43M | 3.9% | +40,000 | New | History |
| Bellus Health Inc New07987C204 | COM NEW | 1,018,327 | $9.41M | 3.9% | +105,000+11.5% | Added | – |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 61,237 | $8.93M | 3.7% | +60,000+4,850.4% | Added | History |
| GOSSGossamer Bio, Inc. | COM | 1,000,387 | $8.37M | 3.5% | +225,072+29.0% | Added | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,379,422 | $8.19M | 3.4% | −549,330−28.5% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 239,441 | $7.28M | 3.0% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,788,853 | $5.58M | 2.3% | −54,379−1.9% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 60,000 | $4.97M | 2.1% | +10,000+20.0% | Added | History |
| PCVXVaxcyte, Inc. | COM | 225,991 | $4.92M | 2.0% | −90,000−28.5% | Reduced | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 86,865 | $4.83M | 2.0% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 246,554 | $4.75M | 2.0% | −150,100−37.8% | Reduced | History |
| SCPHscPharmaceuticals Inc. | COM | 884,008 | $4.26M | 1.8% | −86,090−8.9% | Reduced | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 86,035 | $4.20M | 1.7% | +86,035 | New | History |
| PFEPfizer Inc | Stock | 80,000 | $4.19M | 1.7% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 38,600 | $3.76M | 1.6% | +38,600 | New | History |
| Kraneshares Trust500767306 | CSI CHI INTERNET | 100,000 | $3.28M | 1.4% | +100,000 | New | – |
| STSASatsuma Pharmaceuticals, Inc. | COM | 653,448 | $2.70M | 1.1% | 00.0% | Unchanged | History |
| INSMINSMED Inc | COM PAR $.01 | 125,000 | $2.46M | 1.0% | +125,000 | New | History |
| VKTXViking Therapeutics, Inc. | COM | 835,275 | $2.41M | 1.0% | +302,846+56.9% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 250,000 | $2.26M | 0.9% | +250,000 | New | History |
| ACETAdicet Bio, Inc. | COM | 143,214 | $2.09M | 0.9% | −364,134−71.8% | Reduced | History |
| LYRALyra Therapeutics, Inc. | COM | 347,338 | $1.96M | 0.8% | −75,000−17.8% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 41,900 | $1.89M | 0.8% | +41,900 | New | History |
| SRPTSarepta Therapeutics, Inc. | COM | 25,000 | $1.87M | 0.8% | +25,000 | New | History |
| MCRBSeres Therapeutics, Inc. | COM | 540,624 | $1.85M | 0.8% | −300,000−35.7% | Reduced | History |
| ATXSAstria Therapeutics, Inc. | COM | 592,123 | $1.78M | 0.7% | +499,900+542.1% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 700,000 | $1.74M | 0.7% | +700,000 | New | History |
| XFORX4 Pharmaceuticals, Inc | COM | 1,679,748 | $1.62M | 0.7% | +307,726+22.4% | Added | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 375,000 | $1.50M | 0.6% | 00.0% | Unchanged | History |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 105,000 | $1.45M | 0.6% | +69,851+198.7% | Added | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 316,939 | $1.40M | 0.6% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 157,190 | $1.37M | 0.6% | −624,198−79.9% | Reduced | History |
| NTBLNotable Labs, Ltd. | COM | 830,007 | $1.34M | 0.6% | −740−0.1% | Reduced | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 412,343 | $1.27M | 0.5% | +203,975+97.9% | Added | History |
| MRUSMerus N.V. | COM | 53,703 | $1.22M | 0.5% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 944,431 | $1.00M | 0.4% | −75,639−7.4% | Reduced | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 268,104 | $992.0K | 0.4% | 00.0% | Unchanged | History |
| ARDXArdelyx, Inc. | COM | 1,680,552 | $991.0K | 0.4% | +1,680,552 | New | History |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 181,199 | $942.0K | 0.4% | 00.0% | Unchanged | History |
| FNCHFinch Therapeutics Group, Inc. | COM | 330,523 | $938.0K | 0.4% | 00.0% | Unchanged | History |
| CMRXChimerix Inc | COM | 441,203 | $917.0K | 0.4% | −400,000−47.6% | Reduced | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 322,217 | $912.0K | 0.4% | −50,000−13.4% | Reduced | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 362,537 | $884.0K | 0.4% | 00.0% | Unchanged | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 702,773 | $794.0K | 0.3% | −1,434,355−67.1% | Reduced | History |
| CLVSClovis Oncology, Inc. | COM | 422,339 | $761.0K | 0.3% | −350,000−45.3% | Reduced | History |
| AYLAOld Ayala, Inc | COM | 697,316 | $759.0K | 0.3% | −11,067−1.6% | Reduced | History |
| TARAProtara Therapeutics, Inc. | COM STK | 257,853 | $756.0K | 0.3% | −38,573−13.0% | Reduced | History |
| RNTXRein Therapeutics, Inc. | COM | 2,892,316 | $752.0K | 0.3% | −9,770−0.3% | Reduced | History |
| IRONDisc Medicine, Inc. | COM | 443,096 | $749.0K | 0.3% | 00.0% | Unchanged | History |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 253,432 | $698.0K | 0.3% | −50,729−16.7% | Reduced | History |
| PRDSPardes Biosciences, Inc. | COM | 223,934 | $687.0K | 0.3% | −100,000−30.9% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 20,805 | $632.0K | 0.3% | −66,100−76.1% | Reduced | History |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 523,348 | $617.0K | 0.3% | 00.0% | Unchanged | – |
| TAOXTAO Synergies Inc. | COM NEW | 121,191 | $614.0K | 0.3% | −32,035−20.9% | Reduced | History |
| RCORRenovacor, Inc. | COM | 293,283 | $595.0K | 0.2% | −50,000−14.6% | Reduced | History |
| CNTBConnect Biopharma Holdings Ltd | ADS | 677,859 | $591.0K | 0.2% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 49,372 | $561.0K | 0.2% | −108,470−68.7% | Reduced | History |
| SYBXSynlogic, Inc. | COM | 474,360 | $545.0K | 0.2% | −45,415−8.7% | Reduced | History |
| EOLSEvolus, Inc. | COM | 45,516 | $529.0K | 0.2% | +45,516 | New | History |
| OKUROnKure Therapeutics, Inc. | COM | 185,597 | $491.0K | 0.2% | 00.0% | Unchanged | History |
| ISEEIVERIC bio, Inc. | COM | 49,099 | $473.0K | 0.2% | 00.0% | Unchanged | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM NEW | 132,014 | $378.0K | 0.2% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
| NXTCNextCure, Inc. | COM | 71,435 | $336.0K | 0.1% | −69,623−49.4% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 98,039 | $318.0K | 0.1% | −950,000−90.6% | Reduced | History |
| ZLABZai Lab Ltd | ADR | 81,843 | $278.0K | 0.1% | 00.0% | Unchanged | History |
| VSTMVerastem, Inc. | COM | 228,023 | $265.0K | 0.1% | −450,000−66.4% | Reduced | History |
| Immunoprecise Antibodies Ltd45257F200 | COM NEW | 61,433 | $237.0K | 0.1% | −16,217−20.9% | Reduced | – |
| HEPAHepion Pharmaceuticals, Inc. | COM | 410,189 | $235.0K | 0.1% | −171,948−29.5% | Reduced | History |
| BIIBBiogen Inc. | COM | 1,122 | $228.0K | 0.1% | 00.0% | Unchanged | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM | 862,527 | $217.0K | 0.1% | −135,100−13.5% | Reduced | History |
| RGLSRegulus Therapeutics Inc. | COM | 105,341 | $217.0K | 0.1% | −23,572−18.3% | ReducedConverted for a 1-for-10 split | History |
| IMUXImmunic, Inc. | COM | 61,500 | $214.0K | 0.1% | +61,500 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 300,000 | $200.0K | 0.1% | +300,000 | New | History |
| MREOMereo BioPharma Group plc | SPON ADS | 615,856 | $199.0K | 0.1% | −300,000−32.8% | Reduced | History |
| KAKineta, Inc. | COM | 104,392 | $190.0K | 0.1% | −131,892−55.8% | Reduced | History |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 970,747 | $185.0K | 0.1% | 00.0% | Unchanged | – |
| CLNNClene Inc. | COMMON STOCK | 70,000 | $177.0K | 0.1% | −444,283−86.4% | Reduced | History |
| QCLSQ/C Technologies, Inc. | COM | 81,089 | $176.0K | 0.1% | −50,300−38.3% | Reduced | History |
| MBIOMustang Bio, Inc. | COM | 246,824 | $145.0K | 0.1% | −300,000−54.9% | Reduced | History |
| TPSTTempest Therapeutics, Inc. | COM | 61,827 | $132.0K | 0.1% | 00.0% | Unchanged | History |
| Stealth Biotherapeutics Corp85789A105 | SPONSORED ADS | 501,836 | $127.0K | 0.1% | 00.0% | Unchanged | – |
| Bio Green Med Solution, Inc.23254L603 | COM | 104,741 | $113.0K | <0.1% | 00.0% | Unchanged | – |
| LRMRLarimar Therapeutics, Inc. | COM | 51,606 | $100.0K | <0.1% | 00.0% | Unchanged | History |
| IVAInventiva S.A. | ADS | 15,579 | $93.0K | <0.1% | 00.0% | Unchanged | History |
| DRUGBright Minds Biosciences Inc. | COM | 105,958 | $86.0K | <0.1% | 00.0% | Unchanged | History |
| DFTXDefinium Therapeutics, Inc. | COM | 105,958 | $68.0K | <0.1% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 26,831 | $59.0K | <0.1% | −711,541−96.4% | Reduced | History |
| ENVBEnveric Biosciences, Inc. | COM NEW | 223,834 | $48.0K | <0.1% | −200,000−47.2% | Reduced | History |
| CYTOFAltamira Therapeutics Ltd. | SHS | 75,000 | $36.0K | <0.1% | −245,010−76.6% | Reduced | History |
| BXRXBaudax Bio, Inc. | COM NEW | 2,966 | $3.00K | <0.1% | 00.0% | Unchanged | History |
| KDNYChinook Therapeutics, Inc. | COM | 332,295 | $0 | 0.0% | +332,295 | New | History |
| OTICOtonomy, Inc. | COM | 180 | $0 | 0.0% | −218,358−99.9% | Reduced | History |
Options (34)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | $5.82M | $42.5M |
| AXSMAxsome Therapeutics, Inc. | COM | $19.2M | $13.4M |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $16.6M | $13.7M |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $26.0M | – |
| AMGNAmgen Inc | Stock | – | $24.3M |
| BIIBBiogen Inc. | COM | – | $22.9M |
| KRTXKaruna Therapeutics, Inc. | COM | $12.7M | – |
| RLMDRelmada Therapeutics, Inc. | COM | $5.36M | $5.70M |
| KZRKezar Life Sciences, Inc. | COM | – | $8.89M |
| BMRNBiomarin Pharmaceutical Inc | COM | – | $8.84M |
| SAGESage Therapeutics, Inc. | COM | – | $8.07M |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $7.98M |
| SRPTSarepta Therapeutics, Inc. | COM | – | $7.50M |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $6.76M |
| LNTHLantheus Holdings, Inc. | Stock | – | $6.60M |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $5.57M |
| RETAReata Pharmaceuticals Inc | CL A | – | $4.92M |
| ICPTIntercept Pharmaceuticals, Inc. | COM | – | $4.83M |
| ALTAltimmune, Inc. | COM NEW | – | $3.55M |
| VRDNViridian Therapeutics, Inc. | COM | – | $3.47M |
| BPMCBlueprint Medicines Corp | COM | – | $3.23M |
| LONALeonaBio, Inc. | COM | $609.0K | $2.39M |
| GOSSGossamer Bio, Inc. | COM | – | $2.80M |
| ISEEIVERIC bio, Inc. | COM | – | $2.35M |
| ITOSiTeos Therapeutics, Inc. | COM | – | $2.06M |
| RCUSArcus Biosciences, Inc. | COM | $1.27M | $588.0K |
| BBIOBridgeBio Pharma, Inc. | COM | – | $1.82M |
| MISTMilestone Pharmaceuticals Inc. | COM | – | $1.26M |
| Bellus Health Inc New07987C204 | COM NEW | – | $924.0K |
| TCDATricida, Inc. | COM | $899.0K | – |
| FULCFulcrum Therapeutics, Inc. | COM | – | $893.0K |
| CFRXCONTRAFECT Corp | COM NEW | $615.0K | – |
| PRAXPraxis Precision Medicines, Inc. | COM | – | $263.0K |
| IMUXImmunic, Inc. | COM | $213.0K | – |
Sold out since Q1 2022 (72)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 478,784 | $21.0M | 6.4% | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 202,203 | $9.33M | 2.8% | History |
| SAGESage Therapeutics, Inc. | COM | 249,907 | $8.27M | 2.5% | History |
| BHVNBiohaven Ltd. | COM | 60,000 | $7.11M | 2.2% | History |
| SRRASierra Oncology, Inc. | COM NEW | 217,915 | $6.98M | 2.1% | History |
| AMGNAmgen Inc | Stock | 20,000 | $4.84M | 1.5% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 47,408 | $3.44M | 1.0% | History |
| SVRASavara Inc | COM | 1,622,552 | $2.13M | 0.6% | History |
| KYMRKymera Therapeutics, Inc. | COM | 50,000 | $2.12M | 0.6% | History |
| LQDALiquidia Corp | COM NEW | 243,904 | $1.75M | 0.5% | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 49,997 | $1.73M | 0.5% | History |
| MGNXMacrogenics Inc | COM | 164,119 | $1.45M | 0.4% | History |
| NUVBNuvation Bio Inc. | COM CL A | 213,310 | $1.12M | 0.3% | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 87,071 | $1.08M | 0.3% | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 78,550 | $1.07M | 0.3% | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 8,763 | $1.03M | 0.3% | History |
| MXCTMaxcyte, Inc. | COM | 137,958 | $964.0K | 0.3% | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 510,126 | $837.0K | 0.3% | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 77,274 | $762.0K | 0.2% | – |
| PBLAPanbela Therapeutics, Inc. | COM | 355,959 | $750.0K | 0.2% | History |
| QSIQuantum-Si Inc | COM CL A | 157,363 | $736.0K | 0.2% | History |
| IFRXInflaRx N.V. | COM | 349,468 | $639.0K | 0.2% | History |
| PLRXPliant Therapeutics, Inc. | COM | 90,805 | $636.0K | 0.2% | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 511,186 | $633.0K | 0.2% | History |
| SLDBSolid Biosciences Inc. | COM | 521,155 | $625.0K | 0.2% | History |
| TENXTenax Therapeutics, Inc. | COM NEW | 735,097 | $596.0K | 0.2% | History |
| RLMDRelmada Therapeutics, Inc. | COM | 21,801 | $588.0K | 0.2% | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 39,730 | $586.0K | 0.2% | History |
| KRSAKorsana Biosciences, Inc. | COM | 527,462 | $585.0K | 0.2% | History |
| HARPHarpoon Therapeutics, Inc. | COM | 117,009 | $582.0K | 0.2% | History |
| AVTXAvalo Therapeutics, Inc. | COM | 764,271 | $554.0K | 0.2% | History |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 221,252 | $553.0K | 0.2% | History |
| VTVTvTv Therapeutics Inc. | CL A | 742,980 | $536.0K | 0.2% | History |
| KODKodiak Sciences Inc. | COM | 68,100 | $526.0K | 0.2% | History |
| ASMBAssembly Biosciences, Inc. | COM | 227,076 | $468.0K | 0.1% | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 159,390 | $441.0K | 0.1% | History |
| AGTCApplied Genetic Technologies Corp | COM | 412,293 | $440.0K | 0.1% | History |
| IRDOpus Genetics, Inc. | COM | 124,021 | $401.0K | 0.1% | History |
| NRSNNeuroSense Therapeutics Ltd. | ORDINARY SHARES | 100,000 | $397.0K | 0.1% | History |
| GRIGRI Bio, Inc. | COM | 201,758 | $380.0K | 0.1% | History |
| FATEFate Therapeutics Inc | COM | 9,640 | $374.0K | 0.1% | History |
| CDAKCodiak BioSciences, Inc. | COM | 52,177 | $328.0K | 0.1% | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 476,625 | $314.0K | 0.1% | History |
| ONCTOncternal Therapeutics, Inc. | COM | 210,182 | $292.0K | 0.1% | History |
| EYPTEyePoint, Inc. | COM NEW | 22,552 | $274.0K | 0.1% | History |
| AGENAgenus Inc | COM NEW | 108,933 | $267.0K | 0.1% | History |
| GNCAGenocea Biosciences, Inc. | COM NEW | 206,336 | $259.0K | 0.1% | History |
| PASGPassage BIO, Inc. | COM | 71,856 | $223.0K | 0.1% | History |
| SEELSeelos Therapeutics, Inc. | COM | 257,883 | $215.0K | 0.1% | History |
| ACRSAclaris Therapeutics, Inc. | COM | 12,124 | $208.0K | 0.1% | History |
| ATYRaTYR PHARMA INC | COM NEW | 37,017 | $197.0K | 0.1% | History |
| OCULOcular Therapeutix, Inc | COM | 29,644 | $147.0K | <0.1% | History |
| APTOAptose Biosciences Inc. | COM NEW | 106,952 | $147.0K | <0.1% | History |
| PBYIPuma Biotechnology, Inc. | COM | 49,843 | $144.0K | <0.1% | History |
| GMDAGamida Cell Ltd. | SHS | 32,689 | $135.0K | <0.1% | History |
| BTAIQBioXcel Therapeutics, Inc. | COM | 5,428 | $113.0K | <0.1% | History |
| ORTXOrchard Therapeutics plc | ADS | 155,606 | $110.0K | <0.1% | History |
| CMPXCompass Therapeutics, Inc. | COM | 74,171 | $100.0K | <0.1% | History |
| NVAXNovavax Inc | COM NEW | 1,362 | $100.0K | <0.1% | History |
| Amryt Pharma PLC03217L106 | SPONSORED ADS | 37,248 | $70.0K | <0.1% | – |
| ATNXAthenex, Inc. | COM | 80,039 | $68.0K | <0.1% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 1,882 | $46.0K | <0.1% | History |
| IGMSIGM Biosciences, Inc. | COM | 1,587 | $43.0K | <0.1% | History |
| TNGXTango Therapeutics, Inc. | COM | 5,456 | $42.0K | <0.1% | History |
| TRAWTraws Pharma, Inc. | COM NEW | 18,975 | $35.0K | <0.1% | History |
| SLNOSoleno Therapeutics Inc | COM NEW | 128,454 | $29.0K | <0.1% | History |
| PDSBPDS Biotechnology Corp | COM | 3,672 | $22.0K | <0.1% | History |
| KNTEKinnate Biopharma Inc. | COM | 1,990 | $22.0K | <0.1% | History |
| TGTXTG Therapeutics, Inc. | COM | 2,292 | $21.0K | <0.1% | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 830 | $6.00K | <0.1% | History |
| BLUEbluebird bio, Inc. | COM | 306 | $1.00K | <0.1% | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 99 | $1.00K | <0.1% | History |